Prediction in rectal cancer

Area of Science:

• Oncology
• Medical Imaging
• Molecular Biology

Background:

• Rectal cancer treatment is stratified by disease stage into low, intermediate, and high-risk categories.
• Prognostic and predictive markers are crucial for accurate risk classification and treatment allocation.

Purpose of the Study:

• To review current treatment options for rectal cancer based on risk categories.
• To evaluate the utility of existing prognostic and predictive markers.
• To identify emerging markers with potential to enhance clinical decision-making.

Main Methods:

• Literature review of current treatment strategies for rectal cancer.
• Analysis of studies on histopathological, imaging, and biomolecular markers.
• Assessment of recent research on novel prognostic and predictive markers.

Main Results:

• Current prognostic and predictive markers do not yet demonstrate significant independent value for routine clinical practice.
• Recent studies highlight potential advancements in imaging techniques and biomolecular research.

Conclusions:

• Despite limitations, ongoing research in imaging and molecular biology offers future potential for improved rectal cancer management.
• Further validation is needed for new markers before clinical implementation.